In recent years, with the rising prevalence of chronic and infectious diseases, the demand for real-time detection in clinical diagnostics and the need for highly sensitive, portable, and rapid immunoassay methods have been increasing. The combination of microfluidics and immunoassays
The Microfluidic Immunoassay Market was valued at $0.92 billion in 2023 and is projected to grow to $1.59 billion by 2031, starting from an estimated $0.98 billion in 2024, with a CAGR of 7.3% over the forecast period from
The Microfluidic Immunoassay Market is projected to reach $1.47 billion by 2030, at a CAGR of 7.4% during the forecast period, says Meticulous Research® Microfluidic immunoassays use a lab-on-chip microfluidic platform to conduct the